Related Experiment Video
Updated: Aug 31, 2026

Assays for Validating Histone Acetyltransferase Inhibitors
Published on: August 6, 2020
Sequence specific transcription factor, JDP2 interacts with histone and inhibits p300-mediated histone acetylation
Jianzhi Pan1, Chunyuan Jin, Takehide Murata
1Gene Engineering Division, Bioresource Center, RIKEN (The Institute of Physical & Chemical Research), 3-1-1 Koyadai, Tsukuba, Ibaraki 305-0074, Japan.
Abstract:
Jun dimerization protein 2 (JDP2) is a novel member of AP-1 family and acts as a general repressor of a variety of transcription. JDP2 is able to bind to specific sites in target gene such as c-jun by forming homodimer or heterodimers with a Jun/ATF family member to counteract their transcriptional activity. Previously we showed that JDP2 inhibits the retinoic acid (RA) dependent transcription by recruiting a histone deacetylase 3 (HDAC3) complex to the promoter region of the target genes. We present here that JDP2 has an inhibitory activity of acetylation of all core histones mediated by histone acetyltransferase (HAT) both of p300 and PCAF in vitro. The studies of both histone-binding and HAT-inhibitory activity using a variety of recombinant JDP2(s) indicated that JDP2 might target histone itself through the histone-binding domain of JDP2, which is essential but not sufficient for the inhibition of acetylation. Therefore, our data suggested that HAT-inhibitory activity of JDP2 could in part explain the transcriptional repression of several target genes.
Related Concept Videos
RNA Polymerase II Accessory Proteins
RNA Polymerase II Accessory Proteins
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
Co-activators and Co-repressors
Co-activators and Co-repressors
Transcription Factors

